Efficacy and safety of BI 1358894 in patients with borderline personality disorder: results of a phase 2 randomized, placebo-controlled, parallel group dose-ranging trial
Objective: To provide proof-of-concept (PoC), dose-range finding, and safety data for BI 1358894, a TRPC4/5 ion channel inhibitor, in patients with borderline personality disorder (BPD).
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
January 13, 2025
|
| In: |
The journal of clinical psychiatry
Year: 2025, Jahrgang: 86, Heft: 1, Pages: 1-28 |
| ISSN: | 1555-2101 |
| DOI: | 10.4088/jcp.24m15523 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.4088/jcp.24m15523 Verlag, kostenfrei, Volltext: https://www.psychiatrist.com/jcp/efficacy-safety-bi-1358894-borderline-personality-disorder-phase-2-trial/ 
|
| Verfasserangaben: | Jennifer B. Dwyer, MD, PhD; Christian Schmahl, MD; Manabu Makinodan, MD, PhD; Sarah K. Fineberg, MD, PhD; Stephanie Sommer, PhD; Jan Wruck, MS; Ante Jelaska, MD; Abidemi Adeniji, PhD; and Marianne Goodman, MD |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1931575509 | ||
| 003 | DE-627 | ||
| 005 | 20250723092851.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250723s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4088/jcp.24m15523 |2 doi | |
| 035 | |a (DE-627)1931575509 | ||
| 035 | |a (DE-599)KXP1931575509 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 11 |2 sdnb | ||
| 100 | 1 | |a Dwyer, Jennifer Holt |e VerfasserIn |0 (DE-588)170279308 |0 (DE-627)060344636 |0 (DE-576)131178490 |4 aut | |
| 245 | 1 | 0 | |a Efficacy and safety of BI 1358894 in patients with borderline personality disorder |b results of a phase 2 randomized, placebo-controlled, parallel group dose-ranging trial |c Jennifer B. Dwyer, MD, PhD; Christian Schmahl, MD; Manabu Makinodan, MD, PhD; Sarah K. Fineberg, MD, PhD; Stephanie Sommer, PhD; Jan Wruck, MS; Ante Jelaska, MD; Abidemi Adeniji, PhD; and Marianne Goodman, MD |
| 264 | 1 | |c January 13, 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 28 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.07.2025 | ||
| 520 | |a Objective: To provide proof-of-concept (PoC), dose-range finding, and safety data for BI 1358894, a TRPC4/5 ion channel inhibitor, in patients with borderline personality disorder (BPD). | ||
| 700 | 1 | |a Schmahl, Christian |d 1968- |e VerfasserIn |0 (DE-588)1028601611 |0 (DE-627)731311906 |0 (DE-576)376093927 |4 aut | |
| 700 | 1 | |a Makinodan, Manabu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fineberg, Sarah K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sommer, Stephanie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wruck, Jan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jelaska, Ante |e VerfasserIn |4 aut | |
| 700 | 1 | |a Adeniji, Abidemi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goodman, Marianne |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of clinical psychiatry |d Memphis, Tenn. : Physicians Postgraduate Press, 1996 |g 86(2025), 1, Seite 1-28 |h Online-Ressource |w (DE-627)32064832X |w (DE-600)2025649-8 |w (DE-576)095092161 |x 1555-2101 |7 nnas |a Efficacy and safety of BI 1358894 in patients with borderline personality disorder results of a phase 2 randomized, placebo-controlled, parallel group dose-ranging trial |
| 773 | 1 | 8 | |g volume:86 |g year:2025 |g number:1 |g pages:1-28 |g extent:28 |a Efficacy and safety of BI 1358894 in patients with borderline personality disorder results of a phase 2 randomized, placebo-controlled, parallel group dose-ranging trial |
| 856 | 4 | 0 | |u https://doi.org/10.4088/jcp.24m15523 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.psychiatrist.com/jcp/efficacy-safety-bi-1358894-borderline-personality-disorder-phase-2-trial/ |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250723 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1028601611 |a Schmahl, Christian |m 1028601611:Schmahl, Christian |d 60000 |e 60000PS1028601611 |k 0/60000/ |p 2 | ||
| 999 | |a KXP-PPN1931575509 |e 4749056030 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1931575509","id":{"eki":["1931575509"],"doi":["10.4088/jcp.24m15523"]},"origin":[{"dateIssuedDisp":"January 13, 2025","dateIssuedKey":"2025"}],"relHost":[{"id":{"issn":["1555-2101"],"eki":["32064832X"],"zdb":["2025649-8"]},"origin":[{"dateIssuedKey":"1996","dateIssuedDisp":"1996-","publisherPlace":"Memphis, Tenn.","publisher":"Physicians Postgraduate Press"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"title":[{"title_sort":"journal of clinical psychiatry","subtitle":"JCP","title":"The journal of clinical psychiatry"}],"note":["Gesehen am 09.01.25"],"recId":"32064832X","type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"JCP"}],"pubHistory":["Nachgewiesen 57.1996,10 -"],"disp":"Efficacy and safety of BI 1358894 in patients with borderline personality disorder results of a phase 2 randomized, placebo-controlled, parallel group dose-ranging trialThe journal of clinical psychiatry","part":{"text":"86(2025), 1, Seite 1-28","issue":"1","extent":"28","year":"2025","volume":"86","pages":"1-28"}}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"role":"aut","display":"Dwyer, Jennifer Holt","family":"Dwyer","given":"Jennifer Holt"},{"given":"Christian","role":"aut","display":"Schmahl, Christian","family":"Schmahl"},{"given":"Manabu","display":"Makinodan, Manabu","family":"Makinodan","role":"aut"},{"role":"aut","display":"Fineberg, Sarah K.","family":"Fineberg","given":"Sarah K."},{"given":"Stephanie","display":"Sommer, Stephanie","family":"Sommer","role":"aut"},{"given":"Jan","family":"Wruck","display":"Wruck, Jan","role":"aut"},{"given":"Ante","role":"aut","display":"Jelaska, Ante","family":"Jelaska"},{"role":"aut","family":"Adeniji","display":"Adeniji, Abidemi","given":"Abidemi"},{"display":"Goodman, Marianne","family":"Goodman","role":"aut","given":"Marianne"}],"name":{"displayForm":["Jennifer B. Dwyer, MD, PhD; Christian Schmahl, MD; Manabu Makinodan, MD, PhD; Sarah K. Fineberg, MD, PhD; Stephanie Sommer, PhD; Jan Wruck, MS; Ante Jelaska, MD; Abidemi Adeniji, PhD; and Marianne Goodman, MD"]},"note":["Gesehen am 23.07.2025"],"language":["eng"],"physDesc":[{"noteIll":"Illustrationen","extent":"28 S."}],"title":[{"subtitle":"results of a phase 2 randomized, placebo-controlled, parallel group dose-ranging trial","title":"Efficacy and safety of BI 1358894 in patients with borderline personality disorder","title_sort":"Efficacy and safety of BI 1358894 in patients with borderline personality disorder"}]} | ||
| SRT | |a DWYERJENNIEFFICACYAN1320 | ||